Are Ischemic Stroke and Alzheimer’s Disease Genetically Consecutive Pathologies?

Author:

Filippenkov Ivan B.1ORCID,Khrunin Andrey V.1ORCID,Mozgovoy Ivan V.1ORCID,Dergunova Lyudmila V.1,Limborska Svetlana A.1

Affiliation:

1. Laboratory of Human Molecular Genetics, National Research Center “Kurchatov Institute”, Kurchatov Sq. 2, 123182 Moscow, Russia

Abstract

Complex diseases that affect the functioning of the central nervous system pose a major problem for modern society. Among these, ischemic stroke (IS) holds a special place as one of the most common causes of disability and mortality worldwide. Furthermore, Alzheimer’s disease (AD) ranks first among neurodegenerative diseases, drastically reducing brain activity and overall life quality and duration. Recent studies have shown that AD and IS share several common risk and pathogenic factors, such as an overlapping genomic architecture and molecular signature. In this review, we will summarize the genomics and RNA biology studies of IS and AD, discussing the interconnected nature of these pathologies. Additionally, we highlight specific genomic points and RNA molecules that can serve as potential tools in predicting the risks of diseases and developing effective therapies in the future.

Funder

Russian Science Foundation

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Reference199 articles.

1. Incremental Medical Cost of Delirium in Elderly Patients with Cognitive Impairment: Analysis of a Nationwide Administrative Database in Japan;Igarashi;BMJ Open,2022

2. Declínio Cognitivo Subjetivo, Comprometimento Cognitivo Leve e Demência—Diagnóstico Sindrômico: Recomendações Do Departamento Científico de Neurologia Cognitiva e Do Envelhecimento Da Academia Brasileira de Neurologia;Smid;Dement. Neuropsychol.,2022

3. Epidemiology and the Global Burden of Stroke;Mukherjee;World Neurosurg.,2011

4. GBD 2019 Stroke Collaborators (2021). Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet Neurol, 12, 941–948.

5. Alzheimer’s Disease: Epidemiology and Clinical Progression;Byrnes;Neurol. Ther.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3